Arboretum Ventures, a leading healthcare venture capital firm, today announced the promotion of Tom Shehab, M.D. to Managing Director. Dr. Shehab began his career at Arboretum in 2014 as a Principal after spending several years as a member of the Arboretum Technical Advisory Board.
Digital therapy could soon be prescribed and reimbursed like a pharmaceutical drug for patients with chronic substance use disorder. “This could be a watershed moment for digital health,” said Corey McCann, MD, PhD, chief executive officer of Pear Therapeutics, the developer of the software.
Cerêve Inc., a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing of a $38 million Series B round of financing led by KKR, a leading global investment firm.